Peng Ran

ORCID: 0009-0007-7334-8605
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal cell carcinoma treatment
  • Venous Thromboembolism Diagnosis and Management
  • Network Security and Intrusion Detection
  • Cryptography and Data Security
  • Advanced X-ray and CT Imaging
  • Blockchain Technology Applications and Security
  • User Authentication and Security Systems
  • Risk and Safety Analysis
  • Congenital Heart Disease Studies
  • Radiation Effects in Electronics
  • Adversarial Robustness in Machine Learning
  • Vascular Anomalies and Treatments
  • Explainable Artificial Intelligence (XAI)
  • Advanced Malware Detection Techniques
  • Internet Traffic Analysis and Secure E-voting
  • Smart Grid and Power Systems
  • Bladder and Urothelial Cancer Treatments
  • Artificial Intelligence in Healthcare and Education
  • Software Reliability and Analysis Research
  • Cardiac tumors and thrombi
  • Digital Media Forensic Detection
  • Banking stability, regulation, efficiency
  • Anomaly Detection Techniques and Applications
  • Pulmonary Hypertension Research and Treatments
  • Urinary and Genital Oncology Studies

Peking University
2020-2024

Peking University Third Hospital
2020-2024

China Mobile (China)
2019-2024

China Academy of Safety Sciences and Technology
2023

Beihang University
2021

Nanyang Medical College
2017

Abstract Background Surgical treatment for renal cell carcinoma (RCC) and inferior vena cava (IVC) tumor thrombus (TT) is difficult, the postoperative complication rate high. This study aimed to explore safety oncologic outcomes of neoadjuvant stereotactic ablative body radiotherapy (SABR) combined with surgical RCC IVC-TT. Methods Patients IVC-TTs were enrolled in this study. All patients received SABR focused on IVC at a dose 30 Gy 5 fractions, followed by 2 ~ 4 weeks rest. Then, radical...

10.1186/s12894-024-01405-y article EN cc-by BMC Urology 2024-02-03

To compare the operation complexity and prognosis of completely laparoscopic versus open radical nephrectomy infrahepatic tumor thrombectomy. We reviewed analyzed clinical data 87 patients with thrombus from January 2015 to April 2019 retrospectively. Completely thrombectomy was completed in 41 cases, surgery 46 cases. All successfully operation, there were no cases death during operation. The group older, had smaller renal diameter, shorter median time, lower intraoperative hemorrhage...

10.1016/j.asjsur.2020.12.003 article EN cc-by-nc-nd Asian Journal of Surgery 2020-12-18

Abstract Objective To describe the clinical characteristics of renal cell carcinoma (RCC) with venous tumor thrombus (VTT) and bland (BT), to evaluate influence BT on surgical treatment cancer‐specific survival (CSS) RCC VTT. Methods We retrospectively reviewed data 123 patients VTT, who underwent in our center between February 2015 May 2018. Patients were divided into group (21 patients) non‐BT (102 patients). Chi‐square Mann‐Whitney U test used for categorical continuous variables...

10.1002/cam4.3264 article EN cc-by Cancer Medicine 2020-07-06

With the development of Internet Things (IoT) technology, massive heterogeneous equipment involving all walks life has been connected to networks. However, many current authentication methods have poor robustness and cannot ensure safety access due complexity uncertainty network environment. To deal with this problem, a hierarchical system was proposed in paper. First, an identification method (EIM), using stack denoising autoencoders (SDAs), is developed weaken recognize type equipment....

10.1155/2023/8899697 article EN cc-by International Journal of Intelligent Systems 2023-05-24

Abstract Background Surgical treatment for renal cell carcinoma (RCC) and inferior vena cava (IVC) tumor thrombus (TT) is difficult has a high postoperative complication rate. This study aims to explore the safety oncologic outcomes of neoadjuvant stereotactic ablative body radiotherapy (SABR) combined with surgical RCC IVC-TT. Methods Patients IVC-TT were enrolled in this study. All them received SABR focused on IVC at dose 30 Gy 5 fractions, followed by 2 ~ 4 weeks rest. Then, radical...

10.21203/rs.3.rs-3511682/v1 preprint EN cc-by Research Square (Research Square) 2023-11-07

This study was designed to determine the effect of sildenafil treatment on postoperative hypoxemia with high resistance in cyanotic congenital heart disease. A total 247 cases disease were operated from May 2006 August 2014. Only 45 exhibited after symptomatic treatment. Sildenafil at doses 0.30-5 mg/kg every 6 h administered 24 while other 21 a placebo (the control group). The partial pressure oxygen arterial blood (PaO2), systolic pressure, pulmonary and positive inotropic drugs score...

10.3844/ajbbsp.2017.140.147 article EN American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology 2017-03-01
Coming Soon ...